|
| 37921028 | Assessment of The Utility of The Sarcoma DNA Methylation Classifier In Surgical Pathology. | Am J Surg Pathol | 2024 |
| 37921028 | Assessment of The Utility of The Sarcoma DNA Methylation Classifier In Surgical Pathology. | Am J Surg Pathol | 2024 |
| 37899499 | Utility of Immunohistochemistry With Antibodies to SS18-SSX Chimeric Proteins and C-Terminus of SSX Protein for Synovial Sarcoma Differential Diagnosis. | Am J Surg Pathol | 2024 |
| 37899499 | Utility of Immunohistochemistry With Antibodies to SS18-SSX Chimeric Proteins and C-Terminus of SSX Protein for Synovial Sarcoma Differential Diagnosis. | Am J Surg Pathol | 2024 |
| 36302175 | A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma. | Clin Cancer Res | 2023 |
| 36302175 | A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma. | Clin Cancer Res | 2023 |
| 36073677 | Dataset for reporting of gastrointestinal stromal tumours: recommendations from the International Collaboration on Cancer Reporting (ICCR). | Histopathology | 2023 |
| 37707375 | Early Immune Changes Support Signet Ring Cell Dormancy in CDH1-Driven Hereditary Diffuse Gastric Carcinogenesis. | Mol Cancer Res | 2023 |
| 37966258 | Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 Participants. | Cancer Res Commun | 2023 |
| 37347686 | The NIH pediatric/young adult chordoma clinic and natural history study: Making advances in a very rare tumor. | Pediatr Blood Cancer | 2023 |
| 36776716 | Association of <i>CDH1</i> Germline Variants and Colon Polyp Phenotypes in Patients with Hereditary Diffuse Gastric Cancer. | Gastro Hep Adv | 2023 |
| 36773602 | Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma. | Cell Rep Med | 2023 |
| 37398992 | Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma. | Clin Cancer Res | 2023 |
| 37075315 | An unusual case of metastatic diffuse midline glioma in an adult. | J Neuropathol Exp Neurol | 2023 |
| 36754859 | CD70 and PD-L1 (CD274) co-expression predicts poor clinical outcomes in patients with pleural mesothelioma. | J Pathol Clin Res | 2023 |
| 37307874 | Lipoblastoma-Like Tumor and Fibrosarcoma-Like Lipomatous Neoplasm Represent the Same Entity: A Clinicopathologic and Molecular Genetic Study of 23 Cases Occurring in Both Men and Women at Diverse Locations. | Mod Pathol | 2023 |
| 36991390 | First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors. | J Exp Clin Cancer Res | 2023 |
| 36990610 | Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study. | Lancet Oncol | 2023 |
| 37101182 | Correction: First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors. | J Exp Clin Cancer Res | 2023 |
| 37966258 | Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 Participants. | Cancer Res Commun | 2023 |
| 37707375 | Early Immune Changes Support Signet Ring Cell Dormancy in CDH1-Driven Hereditary Diffuse Gastric Carcinogenesis. | Mol Cancer Res | 2023 |
| 36991390 | First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors. | J Exp Clin Cancer Res | 2023 |
| 36990610 | Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study. | Lancet Oncol | 2023 |
| 37347686 | The NIH pediatric/young adult chordoma clinic and natural history study: Making advances in a very rare tumor. | Pediatr Blood Cancer | 2023 |
| 37075315 | An unusual case of metastatic diffuse midline glioma in an adult. | J Neuropathol Exp Neurol | 2023 |
| 37307874 | Lipoblastoma-Like Tumor and Fibrosarcoma-Like Lipomatous Neoplasm Represent the Same Entity: A Clinicopathologic and Molecular Genetic Study of 23 Cases Occurring in Both Men and Women at Diverse Locations. | Mod Pathol | 2023 |
| 37101182 | Correction: First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors. | J Exp Clin Cancer Res | 2023 |
| 37398992 | Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma. | Clin Cancer Res | 2023 |
| 36776716 | Association of <i>CDH1</i> Germline Variants and Colon Polyp Phenotypes in Patients with Hereditary Diffuse Gastric Cancer. | Gastro Hep Adv | 2023 |
| 36773602 | Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma. | Cell Rep Med | 2023 |
| 36754859 | CD70 and PD-L1 (CD274) co-expression predicts poor clinical outcomes in patients with pleural mesothelioma. | J Pathol Clin Res | 2023 |
| 36073677 | Dataset for reporting of gastrointestinal stromal tumours: recommendations from the International Collaboration on Cancer Reporting (ICCR). | Histopathology | 2023 |
| 34534680 | Molecular Subtypes of Primary SCLC Tumors and Their Associations With Neuroendocrine and Therapeutic Markers. | J Thorac Oncol | 2022 |
| 35973038 | PRAME Expression in Cancer. A Systematic Immunohistochemical Study of >5800 Epithelial and Nonepithelial Tumors. | Am J Surg Pathol | 2022 |
| 36367825 | DNA methylation profiling and histologic analysis of sellar TTF-1-positive papillary epithelial tumor supports a novel CNS entity. | J Neuropathol Exp Neurol | 2022 |
| 36010880 | Performances of Functional and Anatomic Imaging Modalities in <i>Succinate Dehydrogenase A-</i>Related Metastatic Pheochromocytoma and Paraganglioma. | Cancers (Basel) | 2022 |
| 35499461 | Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid Tumors. | Mol Cancer Ther | 2022 |
| 36338744 | Multi-spectral immunofluorescence evaluation of the myeloid, T cell, and natural killer cell tumor immune microenvironment in chordoma may guide immunotherapeutic strategies. | Front Oncol | 2022 |
| 35978013 | Alterations in key signaling pathways in sinonasal tract melanoma. A molecular genetics and immunohistochemical study of 90 cases and comprehensive review of the literature. | Mod Pathol | 2022 |
| 33782093 | Testicular Sertoli cell tumour and potentially testicular Leydig cell tumour are features of <i>DICER1</i> syndrome. | J Med Genet | 2022 |
| 34628055 | Meningiomas in Patients With Malignant Pleural Mesothelioma Harboring Germline BAP1 Mutations. | J Thorac Oncol | 2022 |
| 34534680 | Molecular Subtypes of Primary SCLC Tumors and Their Associations With Neuroendocrine and Therapeutic Markers. | J Thorac Oncol | 2022 |
| 35499461 | Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid Tumors. | Mol Cancer Ther | 2022 |
| 35973038 | PRAME Expression in Cancer. A Systematic Immunohistochemical Study of >5800 Epithelial and Nonepithelial Tumors. | Am J Surg Pathol | 2022 |
| 36338744 | Multi-spectral immunofluorescence evaluation of the myeloid, T cell, and natural killer cell tumor immune microenvironment in chordoma may guide immunotherapeutic strategies. | Front Oncol | 2022 |
| 36367825 | DNA methylation profiling and histologic analysis of sellar TTF-1-positive papillary epithelial tumor supports a novel CNS entity. | J Neuropathol Exp Neurol | 2022 |
| 36010880 | Performances of Functional and Anatomic Imaging Modalities in <i>Succinate Dehydrogenase A-</i>Related Metastatic Pheochromocytoma and Paraganglioma. | Cancers (Basel) | 2022 |
| 35978013 | Alterations in key signaling pathways in sinonasal tract melanoma. A molecular genetics and immunohistochemical study of 90 cases and comprehensive review of the literature. | Mod Pathol | 2022 |
| 33782093 | Testicular Sertoli cell tumour and potentially testicular Leydig cell tumour are features of <i>DICER1</i> syndrome. | J Med Genet | 2022 |
| 34628055 | Meningiomas in Patients With Malignant Pleural Mesothelioma Harboring Germline BAP1 Mutations. | J Thorac Oncol | 2022 |